Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$12.15 - $35.28 $1.23 Million - $3.56 Million
-100,894 Closed
0 $0
Q4 2021

Feb 08, 2022

SELL
$30.49 - $48.49 $29,727 - $47,277
-975 Reduced 0.96%
100,894 $3.44 Million
Q3 2021

Nov 02, 2021

BUY
$41.66 - $52.52 $86,444 - $108,979
2,075 Added 2.08%
101,869 $4.91 Million
Q2 2021

Aug 11, 2021

BUY
$36.62 - $51.69 $98,983 - $139,718
2,703 Added 2.78%
99,794 $4.51 Million
Q1 2021

May 14, 2021

SELL
$41.56 - $59.88 $588,572 - $848,020
-14,162 Reduced 12.73%
97,091 $4.68 Million
Q4 2020

Feb 12, 2021

SELL
$36.08 - $56.47 $5,087 - $7,962
-141 Reduced 0.13%
111,253 $5.99 Million
Q3 2020

Nov 04, 2020

SELL
$33.26 - $40.48 $36,153 - $44,001
-1,087 Reduced 0.97%
111,394 $4.11 Million
Q2 2020

Jul 17, 2020

SELL
$24.21 - $31.02 $513,881 - $658,430
-21,226 Reduced 15.88%
112,481 $3.49 Million
Q1 2020

Apr 21, 2020

BUY
$20.5 - $34.53 $267,566 - $450,685
13,052 Added 10.82%
133,707 $3.69 Million
Q4 2019

Feb 12, 2020

BUY
$18.96 - $29.84 $100,014 - $157,406
5,275 Added 4.57%
120,655 $3.53 Million
Q3 2019

Nov 07, 2019

BUY
$19.12 - $26.24 $151,162 - $207,453
7,906 Added 7.36%
115,380 $2.21 Million
Q2 2019

Aug 06, 2019

BUY
$19.57 - $24.1 $1.49 Million - $1.84 Million
76,264 Added 244.36%
107,474 $2.36 Million
Q1 2019

May 06, 2019

BUY
$12.14 - $20.46 $378,889 - $638,556
31,210 New
31,210 $639,000
Q4 2018

Feb 11, 2019

SELL
$11.24 - $18.5 $251,135 - $413,345
-22,343 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$12.5 - $15.38 $279,287 - $343,635
22,343 New
22,343 $343,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.7B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.